Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Moccia

Showing results (41-50 of 221) with videos related to

Pageof 23
Sort By:
Folia Neuropathologica|July 29, 2015
Are granular osmiophilic material deposits an epiphenomenon in CADASIL?Roberto Erro, Marcello Moccia, Mariarosaria Cervasio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2015
Vitamin K cream reduces reactions at the injection site in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta - VIKING studyRoberta Lanzillo, Marcello Moccia, Antonio Carotenuto, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 23, 2020
Assessing disability and relapses in multiple sclerosis on tele-neurologyMarcello Moccia, Roberta Lanzillo, Vincenzo Brescia Morra, et al.
Multiple Sclerosis and Related Disorders|December 7, 2016
Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosisMarcello Moccia, Raffaele Palladino, Antonio Carotenuto, et al.
Plos One|January 6, 2017
Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015Marcello Moccia, Raffaele Palladino, Roberta Lanzillo, et al.
Nature Reviews. Neurology|January 13, 2018
Assessing treatment outcomes in multiple sclerosis trials and in the clinical settingCarmen Tur, Marcello Moccia, Frederik Barkhof, et al.
Multiple Sclerosis and Related Disorders|November 13, 2017
A 8-year retrospective cohort study comparing Interferon-β formulations for relapsing-remitting multiple sclerosisMarcello Moccia, Raffaele Palladino, Antonio Carotenuto, et al.
Journal of the Neurological Sciences|July 18, 2016
White matter changes and the development of motor phenotypes in de novo Parkinson's DiseaseMarcello Moccia, Enrico Tedeschi, Lorenzo Ugga, et al.
Journal of Clinical Medicine|June 2, 2021
Digital Technology in Clinical Trials for Multiple Sclerosis: Systematic ReviewMarcello De Angelis, Luigi Lavorgna, Antonio Carotenuto, et al.
Multiple Sclerosis and Related Disorders|November 25, 2023
Switching to ozanimod as a strategy to adjust fingolimod-related lymphopeniaDaniele Caliendo, Maria Carmela Grassia, Antonio Carotenuto, et al.
Pageof 23

Showing results (41-50 of 221) with videos related to

Sort By:
Pageof 23
Folia Neuropathologica|July 29, 2015
Are granular osmiophilic material deposits an epiphenomenon in CADASIL?Roberto Erro, Marcello Moccia, Mariarosaria Cervasio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2015
Vitamin K cream reduces reactions at the injection site in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta - VIKING studyRoberta Lanzillo, Marcello Moccia, Antonio Carotenuto, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 23, 2020
Assessing disability and relapses in multiple sclerosis on tele-neurologyMarcello Moccia, Roberta Lanzillo, Vincenzo Brescia Morra, et al.
Multiple Sclerosis and Related Disorders|December 7, 2016
Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosisMarcello Moccia, Raffaele Palladino, Antonio Carotenuto, et al.
Plos One|January 6, 2017
Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015Marcello Moccia, Raffaele Palladino, Roberta Lanzillo, et al.
Nature Reviews. Neurology|January 13, 2018
Assessing treatment outcomes in multiple sclerosis trials and in the clinical settingCarmen Tur, Marcello Moccia, Frederik Barkhof, et al.
Multiple Sclerosis and Related Disorders|November 13, 2017
A 8-year retrospective cohort study comparing Interferon-β formulations for relapsing-remitting multiple sclerosisMarcello Moccia, Raffaele Palladino, Antonio Carotenuto, et al.
Journal of the Neurological Sciences|July 18, 2016
White matter changes and the development of motor phenotypes in de novo Parkinson's DiseaseMarcello Moccia, Enrico Tedeschi, Lorenzo Ugga, et al.
Journal of Clinical Medicine|June 2, 2021
Digital Technology in Clinical Trials for Multiple Sclerosis: Systematic ReviewMarcello De Angelis, Luigi Lavorgna, Antonio Carotenuto, et al.
Multiple Sclerosis and Related Disorders|November 25, 2023
Switching to ozanimod as a strategy to adjust fingolimod-related lymphopeniaDaniele Caliendo, Maria Carmela Grassia, Antonio Carotenuto, et al.
Pageof 23